Ginkgo Bioworks Holdings, Inc.
DNA· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | $168.41M | $44.10M | — |
| Net Income | -$590.51M | -$73.57M | -$25.47M |
| EPS Diluted | -$0.37 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ginkgo Bioworks Holdings, Inc. · CIK 1830214 · Engraved from SEC EDGAR